| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/17/2009 | US20090312293 process for the isolation of pharmacologically active principles of vegetable and animal origin |
| 12/17/2009 | US20090312291 Agent for preventing infection |
| 12/17/2009 | US20090312290 Combination of a nitrogen mustard analogue and imatinib for treatment of chronic lymphocytic leukemia |
| 12/17/2009 | US20090312289 Ibandronate polymorph |
| 12/17/2009 | US20090312288 Kinase inhibitors |
| 12/17/2009 | US20090312287 Multi-carotenoids compositions and methods |
| 12/17/2009 | US20090312286 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 12/17/2009 | US20090312284 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| 12/17/2009 | US20090312283 Branched hyaluronic acid and method of manufacture |
| 12/17/2009 | US20090312282 Novel Low Molecular Weight Hyaluronic Acid and/or Salt Thereof, and Cosmetic Preparation, Pharmaceutical Composition, and Food Composition Each Using Same |
| 12/17/2009 | US20090312281 Process for the preparation of a pulverulent composition and product as obtained |
| 12/17/2009 | US20090312280 Combination therapy of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4-yl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide |
| 12/17/2009 | US20090312278 Treatment of cancers of the blood using selected glycomimetic compounds |
| 12/17/2009 | US20090312277 Compositions And Methods For Reversing Or Preventing Resistance Of A Cancer Cell To A Cytotoxic Agent |
| 12/17/2009 | US20090312276 Compositions and Methods for Treating Cancer |
| 12/17/2009 | US20090312275 Agent for improving insulin resistance |
| 12/17/2009 | US20090312274 Nyasol and Analogs Thereof for the Treatment of Estrogen Receptor Beta-Mediated Diseases |
| 12/17/2009 | US20090312273 Compositions compromising Dimethyl Sulfoxide (DMSO) |
| 12/17/2009 | US20090312272 Transglutaminase inhibitors and methods of use thereof |
| 12/17/2009 | US20090312263 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/17/2009 | US20090312260 Drug therapy for celiac sprue |
| 12/17/2009 | US20090312255 Stimulation of trpv1+ sensory neurons to control beta-cell stress and islet inflammation in diabetes |
| 12/17/2009 | US20090312252 Antimicrobial Activity in Variants of Lacritin |
| 12/17/2009 | US20090312251 Methods of regulating differentiation in mammals |
| 12/17/2009 | US20090312247 Natriuretic peptide related fragment in cardiovascular disease |
| 12/17/2009 | US20090312244 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 12/17/2009 | US20090312242 Flibanserin for the treatment of urinary incontinence and related diseases |
| 12/17/2009 | US20090312237 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling garnitine content in muscle |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311708 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 12/17/2009 | US20090311696 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/17/2009 | US20090311665 Methods, compositions, and kits for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311354 Composition comprising extracts or fractions of magnolia obovata thunb for treating and preventing inflammation disease |
| 12/17/2009 | US20090311347 Combination therapy for bipolar disorder |
| 12/17/2009 | US20090311343 Thiazole Compounds, and Compositions and Methods Using Same |
| 12/17/2009 | US20090311340 Use of xenon as neuroprotectant in a neonatal subject |
| 12/17/2009 | US20090311338 Crosslinking methods and applications thereof |
| 12/17/2009 | US20090311332 Method for forming mesoporous silica nanoparticles, mesoporous silica nanopartices, and applications thereof |
| 12/17/2009 | US20090311331 Pellet Formulation Comprising Colloidal Silicon Dioxide |
| 12/17/2009 | US20090311330 Liquid oral compositions |
| 12/17/2009 | US20090311329 Casein micelles for nanoencapsulation of hydrophobic compounds |
| 12/17/2009 | US20090311327 Oral Therapeutic Compound Delivery System |
| 12/17/2009 | US20090311325 Enhancing solubility and dissolution rate of poorly soluble drugs |
| 12/17/2009 | US20090311322 Atorvastatin formulation |
| 12/17/2009 | US20090311321 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 12/17/2009 | US20090311320 Multilayer orally disintegrating tablet |
| 12/17/2009 | US20090311319 Oral Preparation With Controlled Release |
| 12/17/2009 | US20090311318 Substituted (s)-benzoxazinones |
| 12/17/2009 | US20090311317 Modified release tolterodine formulations |
| 12/17/2009 | US20090311316 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| 12/17/2009 | US20090311315 Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists |
| 12/17/2009 | US20090311314 Tiotropium Containing Powder Formulation For Inhalation |
| 12/17/2009 | US20090311312 Transdermal Hormone Delivery System: Compositions And Methods |
| 12/17/2009 | US20090311308 Skincare compositions comprising salicyclic acid |
| 12/17/2009 | US20090311300 Stent With a Coating or a Basic Body Containing a Lithium Salt and Use of Lithium Salts for Prevention of Restenosis |
| 12/17/2009 | US20090311291 Condoms with lubricant compositions and packaging providing enhanced functionality |
| 12/17/2009 | US20090311288 Imidazoquinoxaline compounds as immunomodulators |
| 12/17/2009 | US20090311287 Novel flavivirus antigens |
| 12/17/2009 | US20090311283 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 12/17/2009 | US20090311278 Novel teleost derived antimicrobial polypeptides |
| 12/17/2009 | US20090311270 Methods, compositions, and kits for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311269 Methods for collecting and detecting oligonucleotides |
| 12/17/2009 | US20090311264 Use of Disorazoles and Their Derivatives for the Treatment of Benign and Malignant Oncoses |
| 12/17/2009 | US20090311263 Human vascular ibp-like growth factor |
| 12/17/2009 | US20090311258 Medicament for lct poisoning |
| 12/17/2009 | US20090311256 12 Human Secreted Proteins |
| 12/17/2009 | US20090311250 Methods and compositions for the diagnosis and treatment of cancer |
| 12/17/2009 | US20090311249 Capecitabine Combination Therapy |
| 12/17/2009 | US20090311242 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 12/17/2009 | US20090311235 Use of Polymeric Materials with Other Substances for Improved Performance |
| 12/17/2009 | US20090311233 Materials and methods directed to asparagine synthetase and asparaginase therapies |
| 12/17/2009 | US20090311231 Product and process for liquefaction of mucus or sputum |
| 12/17/2009 | US20090311230 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 12/17/2009 | US20090311225 Compositions of and Methods of Using Stabilized PSMA Dimers |
| 12/17/2009 | US20090311224 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2 |
| 12/17/2009 | US20090311217 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/17/2009 | US20090311215 Method for treating cervical cancer |
| 12/17/2009 | US20090311206 Cooling cosmetic or dermatological preparations comprising (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1r,2s,5r)-n-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide for reducing skin reddening |
| 12/17/2009 | US20090311201 Lipoxin analogs and methods for the treatment of periodontal disease |
| 12/17/2009 | US20090311194 Methods and compositions for the production and use of magnetosomes |
| 12/17/2009 | US20090311188 In vivo methods of identifying compounds which target suppressed cancer cells |
| 12/17/2009 | US20090311182 Macromolecular Delivery Systems for Non-Invasive Imaging, Evaluation and Treatment of Arthritis and Other Inflammatory Diseases |
| 12/17/2009 | US20090311180 Protein Isoforms and Uses Thereof |
| 12/17/2009 | US20090311176 2-Arylpyrazolo[L,5-Alpha] Pyrimidin-3-YL Acetamide Derivatives as Ligands for Translocator Protein (18 Kda) |
| 12/17/2009 | US20090311175 Methods for treating thyroid cancer |
| 12/17/2009 | DE102008030023A1 Arzneimittel zur Behandlung einer durch Parasiten verursachten Krankheit Medicines used to treat a disease caused by parasitic disease |
| 12/17/2009 | DE102008028071A1 Neue Cokristall-Verbindung von Rivaroxaban und Malonsäure New co-crystal compound of rivaroxaban and malonic acid |
| 12/17/2009 | DE102008027574A1 Neue Pyrrolidinderivate als MetAP-2 Inhibitoren New pyrrolidine derivatives as MetAP-2 inhibitors |
| 12/17/2009 | DE102008015432A1 Verwendung von Pirinixinsäure-Derivaten zur Hemmung der Prostaglandin E2 Synthese Use of Pirinixinsäure derivatives for the inhibition of prostaglandin E2 synthesis |
| 12/17/2009 | DE102008002410A1 Enzymatische Synthese von Sphingolipiden Enzymatic synthesis of sphingolipids |
| 12/17/2009 | DE102008002409A1 Enzymatische Synthese von Sphingolipiden Enzymatic synthesis of sphingolipids |
| 12/17/2009 | CA2731138A1 Compositions for treating rosacea |
| 12/17/2009 | CA2728248A1 Telaprevir dosing regimen |
| 12/17/2009 | CA2727859A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY |
| 12/17/2009 | CA2727847A1 Compositions and methods for treating corneal inflammation |
| 12/17/2009 | CA2727813A1 Crystalline polymorphs of gemcitabine base |
| 12/17/2009 | CA2727788A1 Treatment of cancers of the blood using selected glycomimetic compounds |
| 12/17/2009 | CA2727780A1 Novel potassium channel blockers and uses thereof |
| 12/17/2009 | CA2727710A1 Control of blood vessel physiology to treat skin disorders |
| 12/17/2009 | CA2727684A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor |